Evidence map›Paper›PMID 27153279›Full record

ArticleNature biotechnology2016

A risk-based approach to the regulation of genetically engineered organisms.

Gregory Conko, Drew L Kershen, Henry Miller, Wayne A Parrott

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Overcoming Obstacles to Gene-Edited Solutions to Climate Challenges.Cold Spring Harbor perspectives in biology · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Impacts of the regulatory environment for gene editing on delivering beneficial products.In vitro cellular & developmental biology. Plant : journal of the Tissue Culture Association · 2021
    Article
  10. Article
  11. Review
  12. Review
  13. The evolving EU regulatory framework for precision breeding.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Use of transgenicBulletin of the World Health Organization · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gregory ConkoCompetitive Enterprise Institute, Washington, DC, USA.
Drew L KershenEarl Sneed Centennial Professor of Law Emeritus at the University of Oklahoma College of Law, Norman, Oklahoma, USA.
Henry MillerRobert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution, Stanford University, Stanford, California, USA.
Wayne A ParrottInstitute for Plant Breeding Genetics &Genomics, University of Georgia, Athens, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Government RegulationAgricultureCrops, AgriculturalFood, Genetically ModifiedGenetic EngineeringPlants, Genetically ModifiedRisk AssessmentUnited States

Identifiers

PMID27153279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.